JW Shinyak Corporation (KOSDAQ: 067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,495.00
-8.00 (-0.53%)
Sep 11, 2024, 2:52 PM KST
-48.87%
Market Cap 75.48B
Revenue (ttm) 97.67B
Net Income (ttm) 2.82B
Shares Out 50.69M
EPS (ttm) 55.18
PE Ratio 26.99
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 44,619
Open 1,515.00
Previous Close 1,503.00
Day's Range 1,489.00 - 1,515.00
52-Week Range 1,482.00 - 2,976.19
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About JW Shinyak

JW Shinyak Corporation engages in the production and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatmen... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 231
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.